About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
PEComa of the Lung: A Rare Entity
Vadim G. Pischik1,2, Eugeniy I. Zinchenko1,2, Olga S. Maslak2,  Sergey L. Vorobyev3
1Clinical Hospital 122, Saint Petersburg, Russia; 2Saint Petersburg State University, Faculty of Medicine, Saint Petersburg, Russia; 3National Center of Clinical and Morphological Diagnosis, Saint Petersburg, Russia.
Corresponding Author:
Olga S. Maslak
Email: olga.maslak@me.com
Received: 12-DEC-2018 Accepted: 17-MAR-2019 Published Online: 25-MAR-2019
DOI: http://dx.doi.org/10.17659/01.2019.0016
Abstract
Background: Perivascular epithelioid cell tumor (PEComa) is extremely rare neoplasm, especially for the pulmonary localization. Clear-cell tumor of the lung, arising from perivascular epithelioid cells, has mainly asymptomatic and benign course. The diagnosis is confirmed on the immunohistochemical examination. The tumors are usually benign, but there are some sarcoma-like masses.  Treatment of choice is a surgical resection. Case Report: We report a case of benign PEComa in a 64-year old non-smoking female, accidentally found on a chest X-Ray. VATS anatomic segmentectomy of basal segments was performed.  The immunohistochemical examination showed typical features of PEComa. Conclusion: PEComa should be considered in the differential diagnosis of pulmonary nodules. Surgical resection is a treatment of choice followed by immunostaining.
Keywords : Fluorescence, Perivascular Epithelioid Cell Neoplasms, Solitary Pulmonary Nodule, Thoracic Surgery.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024